Research | OneLook Acronym Finder |
Serial Number | 87503657 |
Registration Number | 5602394 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Kim R. Pearson |
Law Office Assigned | N40 |
Employee Name | WINTER, MELISSA S |
2017-06-23 | Application Filed |
2018-04-24 | Published for Opposition |
2018-05-21 | Date of First Use |
2018-10-02 | Location: PUBLICATION AND ISSUE SECTION |
2018-11-06 | Status: Live/Registered |
2018-11-06 | Trademark Registered |
2018-11-06 | Transaction Date |
Owner: | Tesseract Medical Research, LLC |
Address | 1370 Trancas Street, Suite 350 Napa DE 94558 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing quercetin; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of food supplements, namely, antioxidants for increasing quercetin in the body for supporting respiratory function, promoting stabilization of mast cell membranes, modulating histamine release, and optimizing cytokine profiles; functional nutrient preparations containing quercetin to mitigate histamine release, inflammatory response, and oxidation of LDL cholesterol; specialty nutraceuticals for the dietary management of diseases, disorders, and adverse health conditions that can be remediated with quercetin, namely, exaggerated immune response, exaggerated inflammatory response, and hyperimmune reactions |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-06-27 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-06-30 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-09-21 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-09-28 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-09-28 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-09-28 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-02-21 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-02-21 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-02-21 | 9 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2018-03-21 | 10 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2018-03-21 | 11 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-03-21 | 12 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2018-03-21 | 13 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-21 | 14 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-04-04 | 15 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2018-04-24 | 16 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-04-24 | 17 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-06-19 | 18 NOAM E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2018-08-29 | 19 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-09-22 | 20 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2018-08-29 | 21 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2018-09-27 | 22 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2018-10-02 | 23 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2018-10-03 | 24 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2018-11-06 | 25 R.PR A:Allowance for Publication |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-11-06 | 26 REM1 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.